Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This study is planned to evaluate emotional disorders during treatment by interferon (IFN)
beta in relapsing remitting multiple sclerosis (RRMS) subjects. This is an open-label
exploratory study with no change of therapeutic behavior but with standardized
neuropsychologic follow-up.